Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Accured Expenses (2020 - 2025)

iSpecimen has reported Change in Accured Expenses over the past 6 years, most recently at -$97636.0 for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$97636.0 for Q4 2025, down 166.69% from a year ago — trailing twelve months through Dec 2025 was -$549544.0 (down 47.8% YoY), and the annual figure for FY2025 was -$549544.0, down 47.8%.
  • Change in Accured Expenses for Q4 2025 was -$97636.0 at iSpecimen, down from $71311.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for ISPC hit a ceiling of $562193.0 in Q1 2021 and a floor of -$2.3 million in Q2 2021.
  • Median Change in Accured Expenses over the past 5 years was -$7778.0 (2022), compared with a mean of -$138372.9.
  • Peak annual rise in Change in Accured Expenses hit 6690.99% in 2023, while the deepest fall reached 2164.65% in 2023.
  • iSpecimen's Change in Accured Expenses stood at $657.0 in 2021, then crashed by 1283.87% to -$7778.0 in 2022, then skyrocketed by 6690.99% to $512647.0 in 2023, then crashed by 71.44% to $146413.0 in 2024, then plummeted by 166.69% to -$97636.0 in 2025.
  • The last three reported values for Change in Accured Expenses were -$97636.0 (Q4 2025), $71311.0 (Q3 2025), and -$172687.0 (Q2 2025) per Business Quant data.